The following is a summary of “First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 ...

Based on reporting and leaks, it looks to be a capable device — somewhere between a “last-gen” PlayStation 4 or Xbox One and the current Xbox Series S. The system’s graphics processing ...

Suzhou Genhouse Bio Co. Ltd. has disclosed tyrosine-protein phosphatase non-receptor type 11 (PTPN11; PTP-2C; SHP-2) inhibitors reported to be useful for the treatment of cancer, Noonan syndrome and ...

The development of CTLA-4 and PD-1 blockage antibodies has triggered to search ... capable of recruiting both SHP-1 and SHP-2 phosphatases. NK cells, nature killer cells; ITIM, immunoreceptor tyrosine ...

Immunotyrosine-based switch motifs (ITSMs), encoded in SLAM-family receptors and PD-1, combine the features of ITAMs and ITIMs by associating with SH2 domain-containing proteins, including SHP-1, ...

The term 4×4 means a four-wheel-drive vehicle. Technically, the first digit is the number of wheels and the second is the number that are driven, so a four-wheel-drive pickup truck is a 4×4 ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Moana's island home of ...

The Center for Teaching, Learning, and Assessment (CTLA) advances teaching and learning excellence at OHIO by providing University-wide resources and championing scholarly teaching that is ...

What’s happening with the Overwatch 2 Vault and when is the next Maximilien’s Vault shop rotation and reset? Here are the details. The Overwatch 2 Vault offers players the option to purchase a bunch ...

A Lon­don-based biotech has emerged from stealth with a per­son­al­ized T cell ther­a­py plat­form that it says could cre­ate treat­ments that over­come the usu­al lim­i­ta­tions … ...

Short-course radiotherapy (SCRT) followed by fruquintinib plus adebrelimab and CAPOX in the total neoadjuvant therapy of locally advanced rectal cancer (LARC): A multicenter, single-arm, open-label, ...

Five months af­ter the FDA blocked its plans for ac­cel­er­at­ed ap­proval, Agenus is mov­ing ahead with dis­cus­sions with po­ten­tial phar­ma part­ners to chart a more … ...